Skip to content
10-Q

Quarterly Report

Chemours Co CC

0001627223-26-000011

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 150.38M sh
Shares Diluted Q1 2026 · Mar 31, 2026 150.77M sh
Shares Diluted Q1 2026 · Mar 31, 2025 149.92M sh
Dividends Paid Q1 2026 · Mar 31, 2026 $13M
Dividends Paid Q1 2026 · Mar 31, 2025 $37M
Capex Q1 2026 · Mar 31, 2026 $49M
Capex Q1 2026 · Mar 31, 2025 $84M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$44M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$112M
Long Term Debt Q1 2026 · Mar 31, 2026 $4.1B
Long Term Debt Q1 2026 · Dec 31, 2025 $4.1B
Short Term Debt Q1 2026 · Mar 31, 2026 $37M
Short Term Debt Q1 2026 · Dec 31, 2025 $42M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $563M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $670M
Stockholders Equity Q1 2026 · Mar 31, 2026 $215M
Stockholders Equity Q1 2026 · Dec 31, 2025 $250M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.61B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.69B
Total Liabilities Q1 2026 · Mar 31, 2026 $7.05B
Total Liabilities Q1 2026 · Dec 31, 2025 $7.13B
Current Assets Q1 2026 · Mar 31, 2026 $2.93B
Current Assets Q1 2026 · Dec 31, 2025 $3B
Total Assets Q1 2026 · Mar 31, 2026 $7.27B
Total Assets Q1 2026 · Dec 31, 2025 $7.38B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.19
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.03
Eps Basic Q1 2026 · Mar 31, 2026 −$0.19
Eps Basic Q1 2026 · Mar 31, 2025 −$0.03
Sga Expense Q1 2026 · Mar 31, 2026 $147M
Sga Expense Q1 2026 · Mar 31, 2025 $123M
Rd Expense Q1 2026 · Mar 31, 2026 $26M
Rd Expense Q1 2026 · Mar 31, 2025 $27M
Net Income Q1 2026 · Mar 31, 2026 −$29M
Net Income restated Q1 2026 · Mar 31, 2025 −$5M
Gross Profit Q1 2026 · Mar 31, 2026 $212M
Gross Profit Q1 2026 · Mar 31, 2025 $236M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.17B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.13B
Revenue Q1 2026 · Mar 31, 2026 $1.38B
Revenue Q1 2026 · Mar 31, 2025 $1.37B